BGM Group Ltd (BGM)

• Market cap: $740M
• 1 day: -4.16%
• 5 days: -13.58%
• 1 month: -50.87%
• 3 months: -63.96%
• 6 months: -65.16%
• Year to date: -58.72%
• 1 year: -56.33%
• 5 years: -92.62%
• 10 years: -92.62%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Employees: 323